165 related articles for article (PubMed ID: 31609766)
1. Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway.
Liu Y; Liu C; Tan T; Li S; Tang S; Chen X
Anticancer Drugs; 2019 Nov; 30(10):983-990. PubMed ID: 31609766
[TBL] [Abstract][Full Text] [Related]
2. Sinomenine exerts antitumour effect in gastric cancer cells via enhancement of miR-204 expression.
Yuan H; Zhang J; Li F; Li W; Wang H
Basic Clin Pharmacol Toxicol; 2019 Nov; 125(5):450-459. PubMed ID: 31243880
[TBL] [Abstract][Full Text] [Related]
3. Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis.
Zhou L; Luan H; Liu Q; Jiang T; Liang H; Dong X; Shang H
Mol Med Rep; 2012 May; 5(5):1256-60. PubMed ID: 22367396
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
5. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
[TBL] [Abstract][Full Text] [Related]
6. [6]-Gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K/AKT signaling pathway.
Luo Y; Zha L; Luo L; Chen X; Zhang Q; Gao C; Zhuang X; Yuan S; Qiao T
Phytother Res; 2019 May; 33(5):1353-1362. PubMed ID: 30811726
[TBL] [Abstract][Full Text] [Related]
7. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
8. Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.
Zhou D; Liu W; Liang S; Sun B; Liu A; Cui Z; Han X; Yuan L
Cancer Med; 2018 Apr; 7(4):1369-1383. PubMed ID: 29522284
[TBL] [Abstract][Full Text] [Related]
9. Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway.
Quan Y; Li S; Wang Y; Liu G; Lv Z; Wang Z
Anticancer Agents Med Chem; 2022; 22(11):2098-2108. PubMed ID: 35152870
[TBL] [Abstract][Full Text] [Related]
10. Paris Saponin I Sensitizes Gastric Cancer Cell Lines to Cisplatin via Cell Cycle Arrest and Apoptosis.
Song S; Du L; Jiang H; Zhu X; Li J; Xu J
Med Sci Monit; 2016 Oct; 22():3798-3803. PubMed ID: 27755523
[TBL] [Abstract][Full Text] [Related]
11. Wortmannin enhances cisplatin-induced apoptosis in human ovarian cancer cells in vitro.
Zhao JX; Liu H; Lv J; Yang XJ
Eur Rev Med Pharmacol Sci; 2014; 18(17):2428-34. PubMed ID: 25268086
[TBL] [Abstract][Full Text] [Related]
12. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
[TBL] [Abstract][Full Text] [Related]
13. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
14. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.
Wang G; Lu M; Yao Y; Wang J; Li J
Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effect of sinomenine combined with 5-fluorouracil on colon carcinoma cell growth.
Zhang JX; Yang ZR; Wu DD; Song J; Guo XF; Wang J; Dong WG
Asian Pac J Cancer Prev; 2014; 15(16):6737-43. PubMed ID: 25169518
[TBL] [Abstract][Full Text] [Related]
16. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
Li B; Yang J; Lu Z; Liu B; Liu F
J BUON; 2019; 24(2):739-745. PubMed ID: 31128031
[TBL] [Abstract][Full Text] [Related]
17. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
18.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
19. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
20. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
